-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Addus HomeCare, Lowers Price Target to $142

Benzinga·05/06/2026 14:18:47
Listen to the news
Citizens analyst Constantine Davides maintains Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and lowers the price target from $150 to $142.